Ser220
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.2
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser220  -  MCM2 (human)

Site Information
NVFkERIsDMCkENR   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 2201403

In vivo Characterization
Methods used to characterize site in vivo:
phospho-antibody ( 1 ) , western blotting ( 1 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Kinases, in vitro:
AurA (human) ( 1 ) , CDC7 (human) ( 2 )
Treatments:
nocodazole ( 1 )

References 

1

Perrera C, et al. (2010) Identification of Myb-binding protein 1A (MYBBP1A) as a novel substrate for aurora B kinase. J Biol Chem 285, 11775-85
20177074   Curated Info

2

Charych DH, et al. (2008) Inhibition of Cdc7/Dbf4 kinase activity affects specific phosphorylation sites on MCM2 in cancer cells. J Cell Biochem 104, 1075-86
18286467   Curated Info